1-4 of 4
Thomas Tüting
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complete Regression of Advanced Primary and Metastatic Mouse Melanomas following Combination Chemoimmunotherapy

Judith Kohlmeyer, Mira Cron, Jennifer Landsberg, Tobias Bald, Marcel Renn, Sandra Mikus, Sandra Bondong, Diana Wikasari, Evelyn Gaffal, Gunther Hartmann, Thomas Tüting
Journal: Cancer Research
Cancer Res (2009) 69 (15): 6265–6274.
https://doi.org/10.1158/0008-5472.CAN-09-0579
Published: 29 July 2009
View article titled, Complete Regression of Advanced Primary and Metastatic Mouse Melanomas following Combination Chemoimmunotherapy
Open the PDF for Complete Regression of Advanced Primary and Metastatic Mouse Melanomas following Combination Chemoimmunotherapy in another window
Journal Articles

Therapeutic Efficacy of Antigen-Specific Vaccination and Toll-Like Receptor Stimulation against Established Transplanted and Autochthonous Melanoma in Mice

Damia Tormo, Aleix Ferrer, Pilar Bosch, Evelyn Gaffal, Etiena Basner-Tschakarjan, Jörg Wenzel, Thomas Tüting
Journal: Cancer Research
Cancer Res (2006) 66 (10): 5427–5435.
https://doi.org/10.1158/0008-5472.CAN-06-0399
Published: 16 May 2006
View article titled, Therapeutic Efficacy of Antigen-Specific Vaccination and Toll-Like Receptor Stimulation against Established Transplanted and Autochthonous Melanoma in Mice
Open the PDF for Therapeutic Efficacy of Antigen-Specific Vaccination and Toll-Like Receptor Stimulation against Established Transplanted and Autochthonous Melanoma in Mice in another window
Journal Articles

Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8+ T Lymphocytes

Raffaele De Palma, Ilaria Marigo, Francesco Del Galdo, Carmela De Santo, Paolo Serafini, Sara Cingarlini, Thomas Tüting, Julia Lenz, Giuseppe Basso, Gabriella Milan, Paola Zanovello, Vincenzo Bronte
Journal: Cancer Research
Cancer Res (2004) 64 (21): 8068–8076.
https://doi.org/10.1158/0008-5472.CAN-04-0067
Published: 01 November 2004
View article titled, Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8<sup>+</sup> T Lymphocytes
Open the PDF for Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8<sup>+</sup> T Lymphocytes in another window
Includes: Supplementary data
Journal Articles

Depletion of CD25+ CD4+ T Cells and Treatment with Tyrosinase-related Protein 2-transduced Dendritic Cells Enhance the Interferon α-induced, CD8+ T-Cell-dependent Immune Defense of B16 Melanoma

Julia Steitz, Jürgen Brück, Julia Lenz, Jürgen Knop, Thomas Tüting
Journal: Cancer Research
Cancer Res (2001) 61 (24): 8643–8646.
Published: 01 December 2001
View article titled, Depletion of CD25<sup>+</sup> CD4<sup>+</sup> T Cells and Treatment with Tyrosinase-related Protein 2-transduced Dendritic Cells Enhance the Interferon α-induced, CD8<sup>+</sup> T-Cell-dependent Immune Defense of B16 Melanoma
Open the PDF for Depletion of CD25<sup>+</sup> CD4<sup>+</sup> T Cells and Treatment with Tyrosinase-related Protein 2-transduced Dendritic Cells Enhance the Interferon α-induced, CD8<sup>+</sup> T-Cell-dependent Immune Defense of B16 Melanoma in another window